Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Cedergrenska | 41C | 22. nov 2024 | 2.28 | +3.64 |
Cegedim | C7E | 22. nov 2024 | 10.75 | -2.27 |
Cel-Sci Corp. | LSRM | 22. nov 2024 | 0.56 | -1.75 |
Celanese Corp | DG3 | 22. nov 2024 | 72.16 | +4.82 |
Celestica, Inc. | CTW0 | 22. nov 2024 | 85.50 | -1.72 |
CELL IMPACT AB | ICLA | 22. nov 2024 | 0.02 | +45.19 |
CellaVision | C26 | 22. nov 2024 | 18.28 | +1.67 |
Cellcom Israel Limited | F5U | 22. nov 2024 | 4.72 | +3.51 |
Celldex Therapeutics, Inc. | TCE2 | 22. nov 2024 | 24.80 | 0.00 |
Cellectar Biosciences | NV4 | 22. nov 2024 | 1.47 | +6.52 |
Cellectis | ZVA | 22. nov 2024 | 1.73 | +0.70 |
Cellectis S.A. - American Depositary Shares | ZVAA | 22. nov 2024 | 1.72 | +0.58 |
CELLINK B | 49Z | 22. nov 2024 | 3.07 | -1.66 |
Cellnex Telecom S.A. | 472 | 22. nov 2024 | 32.41 | +2.56 |
Cellnex Telecom SA Unsponsored ADR (Spain) | 4720 | 22. nov 2024 | 15.30 | +2.00 |
Cellular Goods Plc | 6XS | 22. nov 2024 | 0.00 | 0.00 |
Celon Pharma SA | 8RP | 22. nov 2024 | 5.70 | -5.47 |
Celsion Corporation | CBO | 22. nov 2024 | 0.66 | +13.79 |
Celsius Resources Limited | FX8 | 22. nov 2024 | 0.01 | -31.25 |
Celtic plc | CCP | 22. nov 2024 | 1.88 | 0.00 |
Celyad Oncology | 1C0 | 22. nov 2024 | 0.61 | -5.57 |
Cemat | 1X9 | 22. nov 2024 | 0.13 | +1.20 |
CEMBRE S.P.A. EO 0,52 | J0L | 22. nov 2024 | 41.45 | +2.85 |
Cementir Holding N.V. | 3PC | 22. nov 2024 | 11.30 | +4.63 |
Cementos Pacasmayo S.A.A. American Depositary Shares (Each r | EPCC | 22. nov 2024 | 5.60 | -0.89 |
Cemex S.A.B. De C.V. | CEXA | 22. nov 2024 | 5.15 | +0.98 |
Cemex S.A.B. De C.V. CPO | CEXB | 22. nov 2024 | 0.51 | 0.00 |
Cenergy Holdings | 9CN | 22. nov 2024 | 7.82 | -1.01 |
Cenit AG | CSH | 22. nov 2024 | 8.60 | -2.27 |
Cenovus Energy Inc | CXD | 22. nov 2024 | 15.54 | -0.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.